Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

PPAR research

Showing results (71-80 of 679) with videos related to

Pageof 68
Sort By:
PPAR Research|September 5, 2008
Pioglitazone versus Rosiglitazone: Effects on Lipids, Lipoproteins, and Apolipoproteins in Head-to-Head Randomized Clinical StudiesMark A Deeg, Meng H Tan
PPAR Research|January 30, 2007
PPARs and Bone MetabolismBeata Lecka-Czernik
PPAR Research|January 30, 2007
Fine-Tuning Reception in the Bone: PPARgamma and CompanyZ Elizabeth Floyd, Sanjin Zvonic, Mark E Nuttall, et al.
PPAR Research|January 30, 2007
Examination of Ligand-Dependent Coactivator Recruitment by Peroxisome Proliferator-Activated Receptor-alpha (PPARalpha)Eric S Tien, Daniel B Hannon, Jerry T Thompson, et al.
PPAR Research|June 29, 2007
Rosiglitazone, an Agonist of PPARgamma, Inhibits Non-Small Cell Carcinoma Cell Proliferation In Part through Activation of Tumor Sclerosis Complex-2Shouwei Han, Ying Zheng, Jesse Roman
PPAR Research|September 4, 2010
PPARgamma Ligand as a Promising Candidate for Colorectal Cancer Chemoprevention: A Pilot StudyHirokazu Takahashi, Kunihiro Hosono, Takashi Uchiyama, et al.
PPAR Research|July 9, 2010
Regulation of ENaC-Mediated Sodium Reabsorption by Peroxisome Proliferator-Activated ReceptorsTengis S Pavlov, John D Imig, Alexander Staruschenko
PPAR Research|August 14, 2010
The Role of Peroxisome Proliferator-Activated Receptor beta/delta on the Inflammatory Basis of Metabolic DiseaseTeresa Coll, Emma Barroso, David Alvarez-Guardia, et al.
PPAR Research|September 18, 2010
Regulation of PPARγ Coactivator-1α Function and Expression in Muscle: Effect of ExerciseGiulia Uguccioni, Donna D'souza, David A Hood
PPAR Research|July 31, 2010
PPAR-alpha Contributes to the Anti-Inflammatory Activity of Verbascoside in a Model of Inflammatory Bowel Disease in MiceEmanuela Esposito, Emanuela Mazzon, Irene Paterniti, et al.
Pageof 68

Showing results (71-80 of 679) with videos related to

Sort By:
Pageof 68
PPAR Research|September 5, 2008
Pioglitazone versus Rosiglitazone: Effects on Lipids, Lipoproteins, and Apolipoproteins in Head-to-Head Randomized Clinical StudiesMark A Deeg, Meng H Tan
PPAR Research|January 30, 2007
PPARs and Bone MetabolismBeata Lecka-Czernik
PPAR Research|January 30, 2007
Fine-Tuning Reception in the Bone: PPARgamma and CompanyZ Elizabeth Floyd, Sanjin Zvonic, Mark E Nuttall, et al.
PPAR Research|January 30, 2007
Examination of Ligand-Dependent Coactivator Recruitment by Peroxisome Proliferator-Activated Receptor-alpha (PPARalpha)Eric S Tien, Daniel B Hannon, Jerry T Thompson, et al.
PPAR Research|June 29, 2007
Rosiglitazone, an Agonist of PPARgamma, Inhibits Non-Small Cell Carcinoma Cell Proliferation In Part through Activation of Tumor Sclerosis Complex-2Shouwei Han, Ying Zheng, Jesse Roman
PPAR Research|September 4, 2010
PPARgamma Ligand as a Promising Candidate for Colorectal Cancer Chemoprevention: A Pilot StudyHirokazu Takahashi, Kunihiro Hosono, Takashi Uchiyama, et al.
PPAR Research|July 9, 2010
Regulation of ENaC-Mediated Sodium Reabsorption by Peroxisome Proliferator-Activated ReceptorsTengis S Pavlov, John D Imig, Alexander Staruschenko
PPAR Research|August 14, 2010
The Role of Peroxisome Proliferator-Activated Receptor beta/delta on the Inflammatory Basis of Metabolic DiseaseTeresa Coll, Emma Barroso, David Alvarez-Guardia, et al.
PPAR Research|September 18, 2010
Regulation of PPARγ Coactivator-1α Function and Expression in Muscle: Effect of ExerciseGiulia Uguccioni, Donna D'souza, David A Hood
PPAR Research|July 31, 2010
PPAR-alpha Contributes to the Anti-Inflammatory Activity of Verbascoside in a Model of Inflammatory Bowel Disease in MiceEmanuela Esposito, Emanuela Mazzon, Irene Paterniti, et al.
Pageof 68